Format

Send to

Choose Destination
Gac Med Mex. 2009 Nov-Dec;145(6):469-74.

[Prevalence of glycemic control and associated factors in type 2 diabetes mellitus patients at the Hospital Universitario de San Ignacio, Bogotá-Colombia].

[Article in Spanish]

Author information

1
Departamento de Medicina Preventiva y Social, Pontificia Universidad Javeriana, Hospital Universitario de San Ignacio, Bogotá, Colombia. lalba@javeriana.edu.co

Abstract

INTRODUCTION:

Diabetes mellitus is a common disorder worldwide that produces significant morbi-mortality that could be reduced with proper glycemic control.

OBJECTIVE:

Estimate the prevalence of glycemic control in type-2 diabetic patients and explore its association with personal, clinical and familial factors.

MATERIALS AND METHODS:

We conducted a cross-sectional study with 150 type-2 diabetic patients from a chronic diseases program at the Hospital Universitario San Ignacio in Bogota. Clinical and family (type and lifecycle) information was obtained. Adherence to treatment and family function (family-APGAR) were assessed. The prevalence of glycemic control (HbA1C <7%) was estimated and its association with determinant factors was calculated using crude and adjusted odds ratios (OR's).

RESULTS:

The prevalence of glycemic control was 49% (HbA1C <7%) and 63% when we included a different goal for patients over 71 years or with a disease lasting longer than 11 years (HbA1c 7-7.9%). Age, family function, type and adherence to treatment showed significant differences between controlled and uncontrolled patients (p < 0.04). Only family function (OR 1.3 and 7.0 for mild dysfunction and moderate/severe dysfunction respectively) and type of treatment (OR 7.2 for oral therapy and 17.8 for any therapy including insulin) showed an association with glycemic control.

CONCLUSIONS:

Family function and treatment type are relevant factors for glycemic control. A comprehensive approach for diabetes mellitus type-2 is essential to plan effective preventive and therapeutic interventions.

PMID:
20077864
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center